These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7722093)

  • 1. Activity of eight fluoroquinolones against both methicillin-susceptible and -resistant Staphylococcus aureus isolated from skin infections.
    Nishijima S; Namura S; Akamatsu H; Kawai S; Asada Y; Kawabata S; Fujita M
    J Dermatol; 1995 Feb; 22(2):153-5. PubMed ID: 7722093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones.
    Nishijima S; Nakagawa M; Tsuboi N; Akamatsu H; Horio T; Fujita M; Kawabata S
    J Int Med Res; 1996; 24(1):12-6. PubMed ID: 8674789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Smith KR; Cobbs CG
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone resistance among methicillin-resistant staphylococci after usage of fluoroquinolones other than ciprofloxacin in Taiwan.
    Chang SC; Hsieh WC; Luh KT
    Diagn Microbiol Infect Dis; 1994 Jul; 19(3):143-7. PubMed ID: 7820993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of Staphylococcus aureus, isolated from skin infections in 1994, to 19 antimicrobial agents.
    Nishijima S; Nakagawa M; Sugiyama T; Akamatsu H; Horio T; Kawabata S; Fujita M
    J Int Med Res; 1995; 23(5):328-34. PubMed ID: 8529775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC; Chang SC; Hsu LY; Hsieh WC; Luh KT
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of nadifloxacin against both methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus from patients with skin infections.
    Nishijima S; Namura S; Akamatsu H; Kawai S; Asada Y; Kawabata S; Fujita M
    Drugs; 1995; 49 Suppl 2():230-2. PubMed ID: 8549313
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
    Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S
    J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of eight fluoroquinolones against methicillin-resistant Staphylococcus aureus isolated from cutaneous infections.
    Nishijima S; Namura S; Akamatsu H; Asada Y; Kawataba S; Fujita M
    Int J Antimicrob Agents; 1994 Aug; 4(3):147-9. PubMed ID: 18611605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
    Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
    Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
    Chang VS; Dhaliwal DK; Raju L; Kowalski RP
    Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus.
    Sierra JM; Marco F; Ruiz J; Jiménez de Anta MT; Vila J
    Clin Microbiol Infect; 2002 Dec; 8(12):781-90. PubMed ID: 12519351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-resistance of clinical isolates of methicillin-resistant Staphylococcus aureus to aminoglycosides and fluoroquinolones.
    Uete T; Matsuo K; Uete G
    Jpn J Antibiot; 1992 Aug; 45(8):943-8. PubMed ID: 1433900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.
    Maple PA; Hamilton-Miller JM; Brumfitt W
    Antimicrob Agents Chemother; 1991 Feb; 35(2):345-50. PubMed ID: 1827242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
    Wallrauch C; Voss A; Milatovic D; Braveny I
    Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
    Smith SM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):325-6. PubMed ID: 2940966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial activity of nadifloxacin against Staphylococcus and Propionibacterium isolated from patients with dermatological infections].
    Matsuzaki K; Omika K; Hasegawa M; Sato Y; Kobayashi I
    Jpn J Antibiot; 2006 Aug; 59(4):316-20. PubMed ID: 17111596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of twenty-one antimicrobial agents including l-ofloxacin against quinolone-sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureus.
    Peterson LR; Cooper I; Willard KE; Fasching CE; Sinn LM; Shanholtzer CJ; Gerding DN
    Chemotherapy; 1994; 40(1):21-5. PubMed ID: 8306811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.
    Asbell PA; Colby KA; Deng S; McDonnell P; Meisler DM; Raizman MB; Sheppard JD; Sahm DF
    Am J Ophthalmol; 2008 Jun; 145(6):951-958. PubMed ID: 18374299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.
    Yamakawa T; Mitsuyama J; Hayashi K
    J Antimicrob Chemother; 2002 Mar; 49(3):455-65. PubMed ID: 11864945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.